Game Changers Cancer Immunotherapies: Checkpoint Inhibitors


#353220

N/A

IData Insight

$ 1000

In Stock


Report Highlights:
  • How checkpoint inhibitors are revolutionizing treatment options and expectations for cancer patients
  • An overview of global melanoma market
  • Case studies on Opdivo, Keytruda and Yervoy
  • Market potential of Opdivo and Keytruda
A must buy for:

Professional from the pharmaceutical, biotech, medical device and diagnostics industries with responsibilities or involvement in the following areas:
  • Competitive Intelligence
  • Business Intelligence
  • Information Specialist
  • Commercial/Customer Insights
  • Strategic Planning
  • Market/Marketing Research
  • Decision Analysis/Decision Support
  • Business Analytics
  • New Product Planning/Development
  • Forecasting
  • Librarian
  • Brand Management/Product Management
  • Marketing
  • Business Portfolio Planning
  • Strategic/Business Analysis
  • Business Development
  • Licensing
  • Techni cal Anal ysi s
  • Portfolio Management/Planning
  • Project Management
  • Risk Management
  • Research Planning
  • Research & Development
  • Regulatory
  • Scientist
  • Legal/Regulatory
  • Outsourcing
  • Manufacturing